Note D - Notes Receivable	12 Months Ended
Dec. 31, 2017
Notes to Financial Statements
Financing Receivables [Text Block]	NOTE D — NOTES RECEIVABLE In June 2017, Milestone Scientific entered into an agreement for the sale of its interest in Milestone China a forty ( 40% ) percent interest (the “Milestone China Shares”) to an unaffiliated United States domiciled purchaser and a 10 -year option agreement to repurchase the Milestone China Shares. The purchase price for the Milestone China Shares was $1,400,000 of which $125,000 was paid in cash and $1,275,000 was paid by delivery of a non-interest bearing secured promissory note. The note is payable in quarterly installments of $125,000 and is secured by the Milestone China Shares until full repayment. In addition, the purchaser is precluded from selling all or substantially all its assets prior to repayment of the note. The 10 -year option agreement provides Milestone Scientific an option to repurchase the Milestone China Shares at $1,400,000 within the first two years and at fair market value (as defined in such agreement) for the remainder of the 10 -year term. As of March 2, 2018, the promissory note was in default. If Milestone Scientific exercises its rights as a secured party it may be obligated to return to the purchaser up to the $250,000 received for the Milestone China Shares as surplus. At this time Milestone Scientific has not received a response from the purchaser of the Milestone China Shares, Milestone Scientific has not recorded any financial benefit from the sale of Milestone China Shares to date. The transaction has been accounted for as a secured financing and Milestone Scientific will continue to account for its relationship with Milestone China under the equity method of accounting. A note receivable is presented on the Company’s balance sheet, along with a deferral from financing transaction ( $1,400,000 ). The carrying value of the forty ( 40% ) percent investment at the transaction date was zero.

NOTE D — NOTES RECEIVABLE

June 2017,

Milestone Scientific entered into an agreement for the sale of its interest in Milestone China a

forty

(

40%

) percent interest (the “Milestone China Shares”) to an unaffiliated United States domiciled purchaser and a

-year option agreement to repurchase the Milestone China Shares. The purchase price for the Milestone China Shares was

$1,400,000

of which

$125,000

was paid in cash and

$1,275,000

was paid by delivery of a non-interest bearing secured promissory note. The note is payable in quarterly installments of

$125,000

and is secured by the Milestone China Shares until full repayment. In addition, the purchaser is precluded from selling all or substantially all its assets prior to repayment of the note. The

-year option agreement provides Milestone Scientific an option to repurchase the Milestone China Shares at

$1,400,000

within the

first

two

years and at fair market value (as defined in such agreement) for the remainder of the

-year term.

As of

March 2, 2018,

the promissory note was in default. If Milestone Scientific exercises its rights as a secured party it

may

be obligated to return to the purchaser up to the

$250,000

received for the Milestone China Shares as surplus. At this time Milestone Scientific has

not

received a response from the purchaser of the Milestone China Shares, Milestone Scientific has

not

recorded any financial benefit from the sale of Milestone China Shares to date.

The transaction has been accounted for as a secured financing and Milestone Scientific will continue to account for its relationship with Milestone China under the equity method of accounting.

A note receivable is presented on the Company’s balance sheet, along with a deferral from financing transaction (

$1,400,000

). The carrying value of the

forty

(

40%

) percent investment at the transaction date was zero.